¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
°í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå ¼ºÀå°ú µ¿Çâ
¼¼°èÀÇ °í·ÉÀÚ¿ë º¸Çà±â(Elderly Walker) ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2030³â±îÁö 6.9%ÀÇ CAGR·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â 24¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.
³ëÀÎ Àα¸ Áõ°¡, °üÀý¿°, °Ç¿°, ÆÄŲ½¼º´, Àüȯ Àå¾Ö µî¸¸¼º Áúȯ À¯º´·ü Áõ°¡, °í±Þ À̵¿¼º Á¦Ç° °³¹ßÀ» À§ÇÑ R&D ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, »óȯÁ¤Ã¥À» Áö¿øÇÏ´Â Á¤ºÎ ´ëó³ª óġ Èĸ¦ À̾î¹Þ´Â ÀçȰ±â±â³ª ÀåÄ¡ ¼ö¿ä ±ÞÁõµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
¶ÇÇÑ ±â¼úÀûÀ¸·Î ÷´Ü Çõ½ÅÀÌ º¸Çà±â¿¡ º¯È¸¦ ÀÏÀ¸Å°°í ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀÇ Áß¿ä ¿ä¼Ò·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ÆÄŲ½¼º´ ȯÀÚ¿ë ·¹ÀÌÀú°¡ ÀåÂøµÈ ·Ñ·¯¿Í °°Àº »õ·Î¿î ±â´ÉÀ» °®Ãá ÀåÄ¡ µµÀÔÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÅÈï±¹ ½ÃÀå °¡Ã³ºÐ¼Òµæ Áõ°¡¿Í ÀÎÁöµµ Çâ»óÀº ½ÃÀå ¼ö¿ä¸¦ ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
°í·ÉÀÚ¿ë º¸Çà±â »ê¾÷Àº 2020³â COVID-19 ÆÒµ¥¹Í¿¡ È¥¶õÀ» ¹Þ¾Æ ÀåÄ¡ Á¦Á¶ ¹× ¿î¼Û¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. À¯Çà¿¡ µû¸¥ ÀÌ·¯ÇÑ À̵¿¼º ÀåÄ¡ »ý»ê °¨¼Ò´Â 2020³â »ó¹Ý±â »ê¾÷ ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. 2020³â ÈÄ¹Ý ÀÌÈÄ¿¡´Â ±ÔÁ¦°¡ ¿Ïȵǰí Àåºñ ¼ö¿ä¿Í ¿ä±¸°¡ Áõ°¡Ç߱⠶§¹®¿¡ ½ÃÀåÀº À¯¸®ÇÑ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¶ÇÇÑ ½ÉÇ÷°üÁúȯÀ̳ª ½Å°æÁúȯ Áõ·Ê¼ö Áõ°¡, ¿Ü»ó, »ç°íÁõ·Ê¼ö Áõ°¡ °í·ÉȯÀÚ ¼ö¼ú °Ç¼ö ±ÞÁõµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì ½ÃÀåÀº ÁÖµµÀû ÁöÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó ¹ßÀü°ú ÀÇ·áºñ Áõ°¡°¡ Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â ¿äÀÎÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, º¸Çà º¸Á¶ Àåºñ ÀÎÁöµµ Çâ»óÀ¸·Î °í·ÉÀÚ¿ë º¸Çà±â ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
°í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- À¯Çüº°, ½ÃÀåÀº Ç¥ÁØ º¸Çà±â, ¹«¸ º¸Çà±â, ·Ñ·¯·Î ºÐ·ùµË´Ï´Ù. °í·ÉÀÚ Àα¸ ·Ñ·¯ À¯Çü¿¡ ±âÈ£ °íÁ¶¿¡ ÀÇÇØ ·Ñ·¯ À¯ÇüÀº 2022³â °í·ÉÀÚ¿ë º¸Çà±â »ê¾÷ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.
- ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ½ÃÀåÀº º´¿ø, ÀçÅà °£È£ ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2022³â ½ÃÀå Á¡À¯À²Àº º´¿ø ºÎ¹®ÀÌ °¡Àå ÄǽÀ´Ï´Ù. ÀÌ ºÎ¹® ±Þ¼ºÀåÀº ÁÖ·Î ¼ö¼ú °Ç¼ö°¡ ¸¹°í º´¿ø °í·ÉÀÚ¿ë º¸Çà±â »ç¿ë Áõ°¡¿¡ µû¸¥ °ÍÀÔ´Ï´Ù.
- ºÏ¹Ì´Â ³ë³â Àα¸ Áõ°¡, °üÀý¿° ¹× ÆÄŲ½¼º´ À¯º´·ü Áõ°¡·Î ½ÃÀåÀ» µ¶Á¡Çϰí 2022³â 35.6% ÀÌ»óÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀº ƯÈ÷ Áß±¹°ú Àεµ µî ½ÅÈï °æÁ¦±ÇÀÇ ÃÖ±Ù ÀÇ·á ÀÎÇÁ¶ó ÅõÀÚ°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
- ½ÃÀå ¼¼ºÐÈ ¹× ¹üÀ§
- ½ÃÀå Á¤ÀÇ
- Á¤º¸ Á¶´Þ
- ±¸ÀÔÇÑ µ¥ÀÌÅͺ£À̽º
- GVR ³»ºÎ µ¥ÀÌÅͺ£À̽º
- 2Â÷ Á¤º¸¿Í Á¦3ÀÚ ½ÃÁ¡
- 1Â÷ Á¶»ç
- 1Â÷ Á¶»ç »ó¼¼
- Á¤º¸ ºÐ¼®
- ½ÃÀå Çü¼º°ú µ¥ÀÌÅÍ ½Ã°¢È
- µ¥ÀÌÅÍ °ËÁõ ¹× °ø°³
- ½ÃÀå : °è»ê
- 2Â÷ Á¤º¸ ¸®½ºÆ®
- 1Â÷ Á¤º¸ ¸ñ·Ï
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇöȲ
- ºÎ¹® ½º³À¼¦
- °æÀï ±¸µµ ½º³À¼¦
Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå ¼¼ºÐÈ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
- ½ÃÀå µ¿Çâ°ú Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ ºÐ¼®
- »ç¾÷ ȯ°æ ºÐ¼®
- SWOT ºÐ¼® : ¿äÀκ°(Á¤Ä¡, ¹ý·ü, °æÁ¦, ±â¼ú)
- Æ÷ÅÍÀÇ 5¼¼·Â ºÐ¼®
- COVID-19 ¿µÇ⠺м®
Á¦4Àå Á¦Ç° ºñÁî´Ï½º ºÐ¼®
- °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå, À¯Çüº° : Áß¿ä Æ÷ÀÎÆ®
- °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå : À¯Çü ¿òÁ÷ÀÓ°ú ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â)°ú 2030³â
- Ç¥ÁØ º¸Çà±â
- ¼¼°èÀÇ Ç¥ÁØ º¸Çà±â ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)(100¸¸ ´Þ·¯)
- ¹«¸¿ë º¸Çà±â
- ¼¼°èÀÇ ¹«¸¿ë º¸Çà±â ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)100¸¸ ´Þ·¯)
- ·Ñ·¯ À¯Çü
- ¼¼°èÀÇ ·Ñ·¯ ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)100¸¸ ´Þ·¯)
Á¦5Àå ÃÖÁ¾ ¿ëµµ, ºñÁî´Ï½º ºÐ¼®
- °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå, ÃÖÁ¾ ¿ëµµº° : Áß¿ä Æ÷ÀÎÆ®
- °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ¿òÁ÷ÀÓ°ú ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â)°ú 2030³â
- ȨÄɾî
- ¼¼°èÀÇ È¨ ÄÉ¾î ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)(100¸¸ ´Þ·¯)
- º´¿ø
- ¼¼°èÀÇ º´¿ø ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)(100¸¸ ´Þ·¯)
- ±âŸ
- ¼¼°èÀÇ ±âŸ ½ÃÀå Ãß°è, ¿¹Ãø(2018-2030³â)(100¸¸ ´Þ·¯)
Á¦6Àå Áö¿ª ºñÁî´Ï½º ºÐ¼®
- Áö¿ª ½ÃÀå ÇöȲ
- ºÏ¹Ì
- ºÏ¹Ì °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå(2018-2030³â)(100¸¸ ´Þ·¯)
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- À¯·´ °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå(2018-2030³â)(100¸¸ ´Þ·¯)
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå(2018-2030³â)(100¸¸ ´Þ·¯)
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå(2018-2030³â)(100¸¸ ´Þ·¯)
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ¾Æ¸£ÇîÆ¼³ª
- MEA
- MEA °í·ÉÀÚ¿ë º¸Çà±â ½ÃÀå(2018-2030³â)(100¸¸ ´Þ·¯)
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦7Àå °æÀï ±¸µµ
- ȸ»ç ºÐ·ù
- Àü·« ¸ÅÇÎ
- ±â¾÷ ÇÁ·ÎÇÊ, À϶÷Ç¥
- Invacare Corporation
- Drive Medical
- Carex Health Brands
- Medline Industries
- Briggs Healthcare
- Topro USA
- GF Health Products, Inc
- Kaye Products, Inc
- Nova Medical Products
- Just Walkers
NJH 23.07.26
Elderly Walker Market Growth & Trends
The global elderly walker market size is expected to reach USD 2.4 billion by 2030, expanding at 6.9% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increase in geriatric population, rise in prevalence of chronic disorders such as arthritis, tendonitis, Parkinson's disease, conversion disorder, increase in R&D investments for the development of advanced mobility products are some major factors driving the market growth. Furthermore, government initiatives to support reimbursement policies, and the surge in demand for rehabilitation devices and equipment succeeding procedures are other key factors driving the growth of the market.
The technologically advanced innovations are also transforming the walkers, which are expected to serve as a key factor for the market growth during the forecast period. For instance, the introduction of devices with new features such as rollators with the attached laser for Parkinson's patients is anticipated to propel market growth over the forecast period. The rise in disposable income coupled with an increase in awareness in developed countries is anticipated to further boost market demand.
The elderly walkers industry was disrupted during the COVID-19 pandemic in 2020 which affected the manufacturing and transportation of the devices. The decreasing production of these mobility devices owing to the pandemic has negatively affected the industry's growth in the first half of 2020. The market was likely to grow at a lucrative rate after the second half of 2020 as there was an ease of restrictions and an increase in demand and requirement for the devices.
The surge in the number of surgical procedures in elderly patients, due to an increase in cases of cardiovascular and neurological diseases and a rise in the number of trauma & accident cases, is also contributing to the market growth. The North America regional market will retain its leading position throughout the forecast years. Developing healthcare infrastructure and a rise in healthcare expenditure are some of the factors contributing to its large share. Asia Pacific is expected to register the fastest CAGR during the forecast period due to the rising demand for elderly walkers as a result of the growing geriatric population and increasing disposable income and awareness levels about walking aid.
Elderly Walker Market Report Highlights
- Based on type, the market is segmented into standard walkers, knee walkers, and rollators. The rollators segment held the largest revenue share of the elderly walkers industry in 2022, due to the increase in preference of the elder population towards rollators
- Based on end-use, the market has been further categorized into hospitals, home care, and others. The hospitals segment accounted for the largest share of the market in 2022. The segment's rapid growth is primarily attributed to the high number of surgeries performed and the increase in the usage of elderly walkers in hospitals
- The North American region is expected to dominate the market and held the largest revenue share of over 35.6% in 2022, owing to the increasing geriatric population and increase in the prevalence of arthritis and Parkinson's disease
- Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.5.1.1. Approach 1: Commodity flow approach
- 1.6. Data Validation & Publishing
- 1.7. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.5. Market Restraint Analysis
- 3.6. Business Environment Analysis
- 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
- 3.6.2. Porter's Five Forces Analysis
- 3.7. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
- 4.1. Elderly Walkers Market, By Type: Key Takeaways
- 4.2. Elderly Walkers Market: Type Movement & Market Share Analysis, 2022 & 2030
- 4.3. Standard Walkers
- 4.3.1. Global Standard Walkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Knee Walkers
- 4.4.1. Global Knee Walkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Rollators
- 4.5.1. Global Rollators Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. End-Use Business Analysis
- 5.1. Elderly Walkers Market, By End-Use: Key Takeaways
- 5.2. Elderly Walkers Market: End-Use Movement & Market Share Analysis, 2022 & 2030
- 5.3. Home Care
- 5.3.1. Global Home Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Others
- 5.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Regional Business Analysis
- 6.1. Regional Market Snapshot
- 6.2. North America
- 6.2.1. North America Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.2.2. The U.S.
- 6.2.2.1. U.S. Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.2. Germany
- 6.3.2.1. Germany Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.3. UK
- 6.3.3.1. UK Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Italy Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Denmark Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Sweden Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Norway Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.2. Japan
- 6.4.2.1. Japan Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.3. China
- 6.4.3.1. China Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
- 6.4.5.1. South Korea Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.6. Australia
- 6.4.6.1. Australia Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
- 6.4.7.1. Thailand Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.5.3. Mexico
- 6.5.3.1. Mexico Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.5.4. Argentina
- 6.5.4.1. Argentina Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.6. MEA
- 6.6.1. MEA Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. South Africa Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
- 6.6.3.1. Saudi Arabia Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.6.4. UAE
- 6.6.4.1. UAE Elderly Walkers Market, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
- 6.6.5.1. Kuwait Elderly Walkers Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company Categorization
- 7.2. Strategy Mapping
- 7.3. Company Profiles/Listing
- 7.3.1. Invacare Corporation
- 7.3.1.1. Overview
- 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.1.3. Product Benchmarking
- 7.3.1.4. Strategic Initiatives
- 7.3.2. Drive Medical
- 7.3.2.1. Overview
- 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.2.3. Product Benchmarking
- 7.3.2.4. Strategic Initiatives
- 7.3.3. Carex Health Brands
- 7.3.3.1. Overview
- 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.3.3. Product Benchmarking
- 7.3.3.4. Strategic Initiatives
- 7.3.4. Medline Industries
- 7.3.4.1. Overview
- 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.4.3. Product Benchmarking
- 7.3.4.4. Strategic Initiatives
- 7.3.5. Briggs Healthcare
- 7.3.5.1. Overview
- 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.5.3. Product Benchmarking
- 7.3.5.4. Strategic Initiatives
- 7.3.6. Topro USA
- 7.3.6.1. Overview
- 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.6.3. Product Benchmarking
- 7.3.6.4. Strategic Initiatives
- 7.3.7. GF Health Products, Inc
- 7.3.7.1. Overview
- 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.7.3. Product Benchmarking
- 7.3.7.4. Strategic Initiatives
- 7.3.8. Kaye Products, Inc
- 7.3.8.1. Overview
- 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.8.3. Product Benchmarking
- 7.3.8.4. Strategic Initiatives
- 7.3.9. Nova Medical Products
- 7.3.9.1. Overview
- 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.9.3. Product Benchmarking
- 7.3.9.4. Strategic Initiatives
- 7.3.10. Just Walkers
- 7.3.10.1. Overview
- 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 7.3.10.3. Product Benchmarking
- 7.3.10.4. Strategic Initiatives